Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07604220 · ClinicalTrials.gov registry record
Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 115
- Enrollment target
NCT07604220: Clinical Trial study, sponsored by Mayo Clinic.
NCT07604220 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07604220 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 115 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.
Interventions
- OTHER Exosome Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2026-07 |
| Est. Completion | 2028-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07604220
The ClinicalTrials.gov registry entry for NCT07604220 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exosome Analysis is the first listed.
NCT07604220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07604220 about?
NCT07604220 is a clinical study titled "Exosome-based Omic Signatures of Disease Activity in Cardiac Sarcoidosis (EXODACS)". The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidos...
What is the current status of trial NCT07604220?
This trial is currently not yet recruiting. The enrollment target is 115 participants. The study started on 2026-07. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07604220?
The interventions under investigation include: Exosome Analysis (OTHER).
Who is sponsoring clinical trial NCT07604220?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.